ArticleClinical and molecular hepatology2025
Exploring methylation signatures for high de novo recurrence risk in hepatocellular carcinoma.
Da-Won Kim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it